approval
saveELELYSO (TALIGLUCERASE ALFA) — FDA approval
community read0 votes
Sponsor: PFIZER. Form: POWDER. Route: INTRAVENOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalELELYSO (TALIGLUCERASE ALFA) — FDA approvalDec 22, 2025 · 286d ago
- approvalELELYSO (TALIGLUCERASE ALFA) — FDA approvalJan 17, 2025 · 625d ago
- approvalELELYSO (TALIGLUCERASE ALFA) — FDA approvalJul 10, 2024 · 816d ago
- approvalELELYSO (TALIGLUCERASE ALFA) — FDA approvalMay 9, 2023 · 1244d ago
- approvalELELYSO (TALIGLUCERASE ALFA) — FDA approvalAug 30, 2022 · 1496d ago
- approvalELELYSO (TALIGLUCERASE ALFA) — FDA approvalNov 3, 2020 · 2161d ago
- approvalELELYSO (TALIGLUCERASE ALFA) — FDA approvalOct 21, 2019 · 2540d ago
- approvalELELYSO (TALIGLUCERASE ALFA) — FDA approvalDec 20, 2016 · 3575d ago
same company · ±60 days · 5
- approvalCLEOCIN: CLEOCIN T (CLINDAMYCIN PHOSPHATE) — FDA approvalJan 15, 2016
- approvalCLEOCIN: CLEOCIN (CLINDAMYCIN PHOSPHATE) — FDA approvalJan 15, 2016
- approvalCLEOCIN: CLEOCIN T (CLINDAMYCIN PHOSPHATE) — FDA approvalJan 15, 2016
- approvalclindamycin hydrochloride: CLEOCIN HYDROCHLORIDE (CLINDAMYCIN HYDROCHLORIDE) — FDA approvalJan 21, 2016
- approvaltaliglucerase alfa: ELELYSO (TALIGLUCERASE ALFA) — FDA approvalNov 20, 2015
comments(0)
5-min edit window · permanent after that